These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 4738316)

  • 1. Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. I. Activation by tuberculin and by Staphylococcus filtrate.
    Stejskal V; Holm G; Perlmann P
    Cell Immunol; 1973 Jul; 8(1):71-81. PubMed ID: 4738316
    [No Abstract]   [Full Text] [Related]  

  • 2. Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. II. Activation by phytohemagglutinin.
    Stejskal V; Lindberg S; Holm G; Perlmann P
    Cell Immunol; 1973 Jul; 8(1):82-92. PubMed ID: 4199809
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. IV. Competitive inhibition of target cell lysis by addition of unlabeled cells.
    Stejskal V
    Scand J Immunol; 1976; 5(5):479-86. PubMed ID: 822508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergystic action of sera from transplant recipients and lymphocytes activated in vitro.
    Gordon J; MacDonald H; MacLean LD
    Transplant Proc; 1973 Mar; 5(1):429-31. PubMed ID: 4695951
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum-mediated immunological non-reactivity between histoincompatible cells in tetraparental mice.
    Phillips SM; Martin WJ; Shaw AR; Wegmann TG
    Nature; 1971 Nov; 234(5325):146-8. PubMed ID: 4942675
    [No Abstract]   [Full Text] [Related]  

  • 6. Target cell lysis mediated by soluble cytotoxin released from stimulated lymphocytes.
    Peter JB; Dawkins RL
    Nat New Biol; 1971 Jul; 232(29):79-80. PubMed ID: 5285342
    [No Abstract]   [Full Text] [Related]  

  • 7. T-cell mediated immunity in vitro: an analysis of antigen recognition and target cell lysis.
    Feldman M; Cohen IR; Wekerle H
    Transplant Rev; 1972; 12():57-90. PubMed ID: 4119632
    [No Abstract]   [Full Text] [Related]  

  • 8. Morphological changes in normal lymphocytes treated with phytohemagglutinin and methotrexate following their interaction with target cells.
    Bykovskaya SN; Slavina EG; Kadagidze ZG; Chernyakhovskaya IYu
    Bull Exp Biol Med; 1974 Oct; 77(4):421-4. PubMed ID: 4425745
    [No Abstract]   [Full Text] [Related]  

  • 9. Differential cytotoxicity of activated lymphocytes on allogeneic and xenogeneic target cells. III. Species specificity of lymphocyte target cell recognition in vitro.
    Stejskal V; Perlmann P
    Eur J Immunol; 1976 May; 6(5):347-52. PubMed ID: 991906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro cytotoxicity of human lymphocytes: reduction of the lymphocyte cytotoxicity induced by antibodies or phytohemagglutinin by removing immune-complex-binding cells.
    Hallberg T
    Scand J Immunol; 1974; 3(5):645-54. PubMed ID: 4138557
    [No Abstract]   [Full Text] [Related]  

  • 11. Unmasking of xenogeneic neo-antigens on mouse lymphoid cell surfaces by Vibrio cholerae neuraminidase.
    Ray PK; Simmons RL
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):217-22. PubMed ID: 4118961
    [No Abstract]   [Full Text] [Related]  

  • 12. The cytolytic activity of human lymphocytes. I. Cytolytic activity towards PPD-coated target cells in tuberculin positive and negative individuals.
    Rehn TG; Henney CS
    Johns Hopkins Med J; 1972 Oct; 131(4):261-70. PubMed ID: 5081728
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunogenic RNA in the immunotherapy of cancer: the transfer of antitumor cytotoxic activity and tuberculin sensitivity to human lymphocytes using xenogeneic ribonucleic acid.
    Dodd MC; Scheetz ME; Rossio JL
    Ann N Y Acad Sci; 1973 May; 207():454-67. PubMed ID: 4517721
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cellular mechanisms of immunologic facilitation. Study of 2 models in vitro].
    Fontaine J; Oppenheim SE; Voisin GA
    C R Acad Hebd Seances Acad Sci D; 1972 Apr; 274(16):2404-7. PubMed ID: 4624978
    [No Abstract]   [Full Text] [Related]  

  • 15. Association between the beta-2-m-HL-A molecule and membrane structures responsible for lymphocyte activation.
    Solheim BG
    Transplant Rev; 1974; 21(0):35-52. PubMed ID: 4139788
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphocyte in vitro cytotoxicity: characterization of mouse lymphotoxin.
    Kolb WP; Granger GA
    Cell Immunol; 1970 May; 1(1):122-32. PubMed ID: 5535593
    [No Abstract]   [Full Text] [Related]  

  • 17. Allogeneic inhibition in tolerant animals.
    Möller E; Lapp W; Lindholm L
    Transplant Proc; 1969 Mar; 1(1):543-7. PubMed ID: 4944269
    [No Abstract]   [Full Text] [Related]  

  • 18. Cell-mediated immune reactions in vitro: cytotoxicity of lymphocytes activated by phytohemagglutinin and anti-immunoglobulin serum.
    Resch K; Fischer H
    Eur J Immunol; 1971 Aug; 1(4):271-5. PubMed ID: 5316633
    [No Abstract]   [Full Text] [Related]  

  • 19. Failure of neuraminidase to unmask allogeneic antigens on cell surfaces.
    Ray PK; Simmons RL
    Proc Soc Exp Biol Med; 1971 Nov; 138(2):600-4. PubMed ID: 5118473
    [No Abstract]   [Full Text] [Related]  

  • 20. The lysis of fibroblasts by lymphocytes sensitized in vitro: specific antigen activates a nonspecific effect.
    Cohen IR; Feldman M
    Cell Immunol; 1970 Nov; 1(5):521-35. PubMed ID: 4108697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.